A Better Quality of Life and Less Fatigue: New Evidence of the Benefits of Fasting During Chemotherapy

Every year, 8.8 million people worldwide die of cancer and although the recovery rates are increasing, it is estimated that these figures will reach 13 million in 2030. Recently, the journal BMC Cancer published the results of a new clinical trial confirming the benefits of fasting on the quality of life for women diagnosed with breast and ovarian cancer and undergoing chemotherapy, and specifically in the ability of fasting to alleviate fatigue [1]. The paper is authored by a team of researchers from the Department of Internal and Integrative Medicine at the Immanuel Krankenhaus Center, in collaboration with the Institute of Social Medicine, Epidemiology and Health Economics of the Freie University, both in Berlin.